Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Abstract

The Accreditation Subcommittee of the EBMT regularly publishes special reports on current practice of haemopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders in Europe. Major changes have occurred since the first report was published in 1996. Haemopoietic stem cell transplantation today includes grafting with allogeneic and autologous stem cells derived from bone marrow, peripheral blood and cord blood. With reduced intensity conditioning regimens in allogeneic transplantation, the age limit has increased, permitting the inclusion of older patients. New indications have emerged such as autoimmune disorders and AL amyloidosis for autologous, and solid tumours for allogeneic transplants. The introduction of alternative therapies has challenged well-established indications such as imatinib for chronic myeloid leukaemia. An updated report with revised tables and operating definitions is presented here.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Schmitz N, Gratwohl A, Goldman JM . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1996 and proposals for an operational classification. Bone Marrow Transplant 1996; 17: 471–477.

    CAS  Google Scholar 

  2. Goldman JM, Schmitz N, Niethammer D, Gratwohl A . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Bone Marrow Transplant 1998; 21: 1–7.

    Article  CAS  Google Scholar 

  3. Gratwohl A, Hermans J, Baldomero H, Tichelli A, Goldman JM, Gahrton G . Indications for haemopoietic precursor cell transplants in Europe. Br J Haematol 1996; 92: 35–43.

    Article  CAS  Google Scholar 

  4. Urbano-Ispizua A, Schmitz N, de Witte T, Frassoni F, Rosti G, Schrezenmeier H et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002; 29: 639–646.

    Article  CAS  Google Scholar 

  5. Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza Jr FR, Ringden O et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004; 22: 4872–4880.

    Article  Google Scholar 

  6. Link H, Schmitz N, Gratwohl A, Goldman JM . Standards for specialist units undertaking blood and marrow stem cell transplants – recommendations from the EBMT. Bone Marrow Transplant 1995; 16: 733–763.

    CAS  Google Scholar 

  7. Joint Accreditation Committee. EBMT-EuroISHAGE (JACIE) Accreditation Manual (www.jacie.org).

Download references

Acknowledgements

We are grateful for the advice and helpful comments received from a number of individuals across Europe, specialising in the use of haemopoietic stem cell transplantation to treat patients with haematological disorders. We extend special thanks to G Gahrton, R Willemze, J Esteve, H Dombret, P Corradini, P Dreger, C Gisselbrecht, M Trneny, H Greinix, Y Beguin, CG Steward, A Fischer, A Cant, L Notarangelo, W Friedrich, and N Wulffraat.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to P Ljungman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljungman, P., Urbano-Ispizua, A., Cavazzana-Calvo, M. et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 37, 439–449 (2006). https://doi.org/10.1038/sj.bmt.1705265

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705265

Keywords

This article is cited by

Search

Quick links